IL1RA inhibits the progression of oral squamous cell carcinoma by mediating type Ⅰ interferon response

Interleukin-1 receptor antagonist (IL1RA) is an anti-inflammatory and anti-tumor protein, and a member of the Interleukin-1 (IL-1) family. Our previous finding showed that IL1RA is a tumor marker for oral squamous cell carcinoma (OSCC), but the exact mechanism is unknown. The present study aims to i...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Yujie Ding, Yufei Shan, Jiaqi Gu, Jie Yi, Zhida Sun
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Elsevier 2025-08-01
Ráidu:	Translational Oncology
Fáttát:	Oral squamous cell carcinoma Interleukin-1 receptor antagonist Type I interferon response Interferon α Interferon β
Liŋkkat:	http://www.sciencedirect.com/science/article/pii/S1936523325001597
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!